GoviEx Uranium Inc. (CVE:GXU - Get Free Report) fell 5% during trading on Monday . The company traded as low as C$0.13 and last traded at C$0.13. 91,500 shares were traded during trading, a decline of 93% from the average session volume of 1,362,357 shares. The stock had previously closed at C$0.14.
Wall Street Analyst Weigh In
Separately, Eight Capital set a C$0.70 price target on GoviEx Uranium and gave the company a "buy" rating in a research note on Thursday, February 29th.
View Our Latest Report on GoviEx Uranium
GoviEx Uranium Price Performance
The company has a current ratio of 5.04, a quick ratio of 0.62 and a debt-to-equity ratio of 0.40. The stock has a market cap of C$109.71 million, a P/E ratio of -4.33 and a beta of 1.24. The company's fifty day simple moving average is C$0.16 and its 200-day simple moving average is C$0.17.
GoviEx Uranium Company Profile
(
Get Free Report)
GoviEx Uranium Inc, a mineral resources company, engages in the acquisition, exploration, and development of uranium properties in Africa. The company's principal asset is the Madaouela project which holds 80% interest located in north-central Niger. It also owns 100% interest in the Muntanga project that consists of 3 mining licenses situated to the south of Lusaka, Zambia; and the Falea project, which consists of three exploration licenses located in Mali.
See Also
Before you consider GoviEx Uranium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoviEx Uranium wasn't on the list.
While GoviEx Uranium currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
